Orosomucoid in human pregnancy serum diminishes bioavailability of the progesterone antagonist RU 486 in rats.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 2309838.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Bioavailability of the progesterone antagonist RU 486 was examined in vivo by measurement of first-pass uptake by hepatic and uterine tissues in rats. Presence of human pregnancy serum or alpha 1-acid glycoprotein (orosomucoid) in injection vehicles diminished uptake of this steroid, which suggests limited bioavailability. These data indicate that elevated human serum orosomucoid levels may account for some failures of RU 486 in early pregnancy termination.
Medical subject headings
- Mifepristone
- Orosomucoid
- Pregnancy